Nausea and vomiting incidence with semaglutide 2.4 mg reached 44% and 24%, respectively, across STEP trials [2]
CVD: Cardiovascular Disease
The second compound from Innovent is a preclinical immunooncology molecule
Beyond pigmentation, scientific investigations have suggested that MT-1 may interact with multiple physiological pathways, ranging from neurobiology to vascular regulation
Medical spa services vary by provider, eligibility, and treatment plan.
To date, we have devoted substantially all of our resources to identifying, acquiring and developing our product candidates and licensed technologies, building our pipeline, performing research, conducting preclinical studies and early-stage clinical trials, organizing and staffing our company, business planning, establishing and maintaining our intellectual property portfolio, establishing arrangements with third parties for the manufacture of our product candidates, raising capital and providing general and administrative support for these operations